Newsletter

IPOs

DeepSeek Is Preparing to IPO at US$71 Billion. Here’s Why You Can’t Buy It.

DeepSeek, the Chinese company that shocked the tech world in early 2025, is getting ready to go public. Reports say it could file for an initial public offering, or IPO, as soon as late this year, with a listing planned for 2027. Ahead of that, it is raising new money at a US$71 billion valuation.…

ByUjjwal Maheshwari8 hours ago

Tetragon Energy (ASX:TET) lists at A$8m with 483 Bcf already discovered

Tetragon Energy (ASX:TET) lists in July 2026 with 483 Bcf discovered gas across three Philippines permits and an A$8m market cap.

ByCharlie YouldenJuly 9, 2026

Godolphin (ASX:GRL) values Narraburra at A$12.5m in Matrix spinout

Godolphin Resources (ASX:GRL) confirms Matrix Critical Minerals IPO terms and a A$12.5m valuation for the yttrium-rich Narraburra Rare Earths Project.

ByCharlie YouldenJuly 9, 2026

Did any COVID era ASX IPOs actually succeed? Yes and here are 6 of them!

The cohort COVID era ASX IPOs was significantly large, but there were far more dud companies than successes. During 2021, A$13bn in capital was raised and the total value of new listings was $52 billion - with the latter including dual listings, direct listings and spinoffs. The average performance was 17% which was actually better…

ByNick SundichJuly 3, 2026

ASX Stocks to Buy in FY27: Here Are Our Top 10 To Watch!

Today is the first day of the new financial year, and we think plenty of investors are wondering which ASX Stocks to Buy in FY27. Stocks Down Under recaps 10 stocks that it thinks is set for a good 12 months ahead. 10 ASX Stocks to Buy in FY27 Goodman Group (ASX:GMG) Goodman enters FY27 with…

ByNick SundichJuly 1, 2026

After SpaceX, Anthropic Is the Next Mega-IPO: Here’s How Australians Can Get Exposure to US$965bn Giant

KEY POINTS Anthropic, the maker of Claude, has filed to go public and is now the world's most valuable pure-play AI startup at about US$965 billion. Trading in pre-IPO contracts on Anthropic and OpenAI has exploded, a sign of huge investor demand ahead of the listings. Australians cannot buy Anthropic…

ByUjjwal MaheshwariJune 24, 2026

SpaceX (NSDQ:SPCX) The Most Misunderstood US $2T IPO in Decades

Should you buy SpaceX SpaceX is becoming one of the most misunderstood IPOs in market history. With a valuation of around US$2.1 trillion and the stock already gaining 19% in the open market, we would caution investors looking to chase SPCX at current levels. SpaceX reportedly listed at a valuation of US$1.75 trillion, raising more than…

ByCharlie YouldenJune 17, 2026

SpaceX Soars 25% in Record Debut as Musk Becomes First Trillionaire: 3 ASX Ways to Play It

KEY POINTS SpaceX began trading on the Nasdaq on Friday under the ticker SPCX, opening 11% above its US$135 IPO price and rising as much as ~25% on day one, pushing its value above US$2 trillion. The float raised about US$75 billion, the biggest IPO in history, and made Elon Musk the world's…

ByUjjwal MaheshwariJune 13, 2026

ASX IPOs Are Back: 4 New Floats in May, 6 More in June, but Should You Buy?

KEY POINTS Four companies floated on the ASX in May, taking 2026 listings to 16, far ahead of the five at this point last year. Several more floats are lined up for June, including defence-drone maker Boresight (ASX: BST), uranium explorer Neu Horizon and NT-focused Daly Resources (ASX: DLY), spanning defence tech, uranium…

ByUjjwal MaheshwariJune 10, 2026

The SpaceX IPO Isn’t on the ASX: 3 Ways Australians Can Invest Anyway

KEY POINTS SpaceX is on track to become the largest IPO in history, but it is expected to list on the Nasdaq, not the ASX. The Betashares Space Industry ETF (ASX: RCKT) is the most direct ASX-listed way to gain exposure to the global space industry. Nasdaq 100 ETFs such as NDQ…

ByUjjwal MaheshwariJune 4, 2026